Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2017

Mar 2, 2017

31041_dirs_2017-03-02_12583a48-8a1b-4f49-8e76-a7fa11e019da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2017-02-21

Reporting Person: Kuehner John Edward (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8739 Direct
Common Stock 1343 Direct
Common Stock 2241 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $17.2 2018-12-10 Common Stock (11000) Direct
Employee Stock Option (right to buy) $21.39 2019-12-08 Common Stock (18000) Direct
Employee Stock Option (right to buy) $32.21 2020-12-06 Common Stock (13900) Direct
Employee Stock Option (right to buy) $29.06 2022-02-28 Common Stock (11284) Direct
Employee Stock Option (right to buy) $38.1 2023-02-19 Common Stock (9197) Direct
Employee Stock Option (right to buy) $50.32 2024-02-26 Common Stock (4236) Direct
Employee Stock Option (right to buy) $58.52 2025-02-19 Common Stock (7120) Direct
Employee Stock Option (right to buy) $60.85 2026-02-23 Common Stock (2300) Direct
Employee Stock Option (right to buy) $60.85 2026-02-23 Common Stock (15710) Direct
Employee Stock Option (right to buy) $85.4 2027-02-20 Common Stock (16680) Direct

Footnotes

F1: Ownership consists of 3,867 shares held in Reporting Person's Company 401(k)/profit sharing plan account, and 4,872 shares held directly.

F2: Ownership of restricted stock vests in Reporting Person 4 years following the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person, dated February 26, 2014.

F3: Ownership of restricted stock vests in Reporting Person 4 years following the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person, dated February 19, 2015.

F4: Options vest 20% year 1; 40% year 2; and 40% year 3